MedTrace Logo

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

NCT07746427 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-08-07

No results posted yet for this study

Summary

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Conditions

Interventions

BEHAVIORAL

Digital App Mindfulness Meditation

Regular use of a digital mindfulness meditation app 3-4 times per week for 10-15 minutes each session.

BEHAVIORAL

Mindfulness Meditation Sheet

Participants will read an informational handout on mindfulness meditation at the start of the study.

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Dana O'Toole, MD · Weill Medical College of Cornell University

  • Melissa Stockwell, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-15
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07746427 on ClinicalTrials.gov